A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to determine to what extend a treatment with the iron compounds Iron Isomaltoside 1000 or Ferric Carboxymaltose is leading to hypophosphatemia and to study the potential clinical impact of hypophosphatemia.
Epistemonikos ID: d81895f9c1acbe6cb75ced5a5b02200b86af2a3d
First added on: May 17, 2024